SM

Shreelaxmi Makrand Agasti

Active Director Director DIN 10108630
DIN 10108630 First appointment Apr 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Shreelaxmi Makrand Agasti

Data last updated:

Shreelaxmi Makrand Agasti is a Director at Goflaxo Biosciences Private Limited (since 2023). The company operates in Paper.

DIN 10108630
Primary Designation Director
Industry Paper
First Appointment 10 Apr 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Goflaxo Biosciences Private Limited U21009MH2023PTC400447
Director10 Apr 20232023Active

Board colleagues of Shreelaxmi Makrand Agasti

NameDINCompanyDesignation
Urvashi Sharma10108629Goflaxo Biosciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Goflaxo Biosciences Private Limited
Premium access

Shareholding and investment profile for Shreelaxmi Makrand Agasti

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shreelaxmi Makrand Agasti

Shreelaxmi Makrand Agasti currently holds 1 directorship: Goflaxo Biosciences Private Limited (Director, since 10 Apr 2023).

Shreelaxmi Makrand Agasti was first appointed on 10 Apr 2023 as Director at Goflaxo Biosciences Private Limited.

The current boards of Shreelaxmi Makrand Agasti's companies include Urvashi Sharma (Goflaxo Biosciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available